February 28, 2024
AngioDynamics and Immunophotonics Announces Partnership to Explore the Power of Immunotherapy
Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a partnership that will combine use of...
Read More
February 23, 2024
Immunophotonics presenting at the Global Life Science Partnering & Investor Conference February 27-29, 2024
Immunophotonics, Inc. is grateful to NCI (National Cancer Institute) SBIR Investor Initiatives Team for providing us the opportunity to showcase...
Read More
February 13, 2024
Wei Chen’s Publication in Acta Biomaterialia Journal
Congratulations to Professor Wei Chen and his lab at the University of Oklahoma, along with contributors Lu Alleruzzo, Samuel S.K....
Read More
January 9, 2024
St. Louis cancer drug startup’s expansion plans include research pact with pharma giant
St. Louis cancer drug startup Immunophotonics Inc. will pursue expansion of its lead drug candidate through a partnership with the...
Read More
January 24, 2024
SIO Annual Scientific Meeting, January 26 – 29, 2024
Tomas Hode, PhD, Co-Founder, CIO, and President at Immunophotonics, Inc. will be attending the SIO Annual Scientific Meeting January 26...
Read More
January 9, 2024
Spectrum Conference, January 11 – 14, 2024
Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) are looking forward to attending Spectrum Conference, January...
Read More
January 8, 2024
JPM 2024 San Francisco, January 8 – 12, 2024
Our networking is well underway with investors and potential strategic partners for the JPM 2024. Attending the annual summit Lu...
Read More
December 21, 2023
Immunophotonics Announces Research Collaboration to Study Combination of Its Lead Asset with Radiotherapy
Immunophotonics Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President have announced a research collaboration with Johnson & Johnson...
Read More
October 25, 2023
AngioDynamics International Life Symposium October 26 – 28, 2023
Immunophotonics co-founders Lu Alleruzzo, CEO and Tomas Hode, PhD, CIO, and President attending the AngioDynamics International Life Symposium taking place...
Read More
October 19, 2023
ESMO Conference October 20 – 24, 2023
Immunophotonics co-founders Lu Alleruzzo (CEO) and Tomas Hode, PhD (CIO and President) will be attending ESMO Conference, October 20 –...
Read More